Hurlburt Elizabeth 4

What Happened Elizabeth Hurlburt, Chief Operating Officer of CorMedix (CRMD), was granted 93,010 restricted stock units (RSUs) on January 23, 2026 (reported on Form 4 filed Jan 27, 2026). As part of tax withholding, 10,778 shares were surrendered/disposed at a reported withholding price of $7.27 per share, totaling approximately $78,356. The RSU grant itself is reported as an award (code A); the share surrender for taxes is reported under code F.

Key Details

• Transaction date: 2026-01-23; Form 4 filed: 2026-01-27 (timely filing — within required two business days).
• Grant: 93,010 RSUs (each RSU equals one share); reported acquisition price $0.00 (award).
• Tax withholding: 10,778 shares withheld/disposed at $7.27/share = $78,356 (reported as a disposition to cover tax liability).
• Shares owned after the transaction: not specified in the provided filing details.
• Footnote: RSUs vest 1/4 on the grant date and 1/4 each year on the first, second and third anniversaries, subject to continued employment.

Context RSU grants are awards that convert into common shares as they vest — they are not open-market purchases and typically reflect compensation rather than a direct buy or sell signal. The withholding of shares to cover taxes (code F) is a routine administrative step (often a net-share settlement) and does not necessarily indicate a change in insider sentiment.